Trials That Matter: Rosiglitazone, Ramipril, and the Prevention of Type 2 Diabetes
Year: 2007
Type: editorial
Source: Annals of Internal Medicine
Authors: David M. Nathan, Michael Berkwits
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2067982618